Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Pregnancy outcome after use of cranberry in pregnancy – the Norwegian mother and child cohort study

Authors: Kristine Heitmann, Hedvig Nordeng, Lone Holst

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Cranberry is one of the most commonly used herbs during pregnancy. The herb has been used traditionally against urinary tract infections. No studies are found that specifically address the risk of malformations after use of cranberry during pregnancy. The aim of the study was to investigate the safety of cranberry use during pregnancy, including any effects on congenital malformations and selected pregnancy outcomes.

Methods

The study is based on data from The Norwegian Mother and Child Cohort Study including more than 100,000 pregnancies from 1999 to 2008. Information on use of cranberry and socio-demographic factors was retrieved from three self-administered questionnaires completed by the women in pregnancy weeks 17 and 30, and 6 months after birth. Information on pregnancy outcomes was retrieved from the Medical Birth Registry of Norway.

Results

Among the 68,522 women in the study, 919 (1.3%) women had used cranberry while pregnant. We did not detect any increased risk of congenital malformations after use of cranberry. Furthermore, the use of cranberry was also not associated with increased risk for stillbirth/neonatal death, low birth weight, small for gestational age, preterm birth, low Apgar score (<7), neonatal infections or maternal vaginal bleeding in early pregnancy. Although an association was found between use of cranberry in late pregnancy and vaginal bleeding after pregnancy week 17, further sub-analyses of more severe bleeding outcomes did not support a significant risk.

Conclusions

The findings of this study, revealing no increased risk of malformations nor any of the following pregnancy outcomes; stillbirth/neonatal death, preterm delivery, low birth weight, small for gestational age, low Apgar score and neonatal infections are reassuring. However, maternal vaginal bleeding should be investigated further before any firm conclusion can be drawn. Treatment guidelines on asymptomatic bacteriuria in pregnancy recommend antimicrobial therapy as the first line treatment. According to our data and the outcomes studied, cranberry does not appear to be a harmful adjunctive self-treatment.

Literature
  1. Blumenthal M: The ABC Clinical Guide to Herbs. 2003, New York: American Botanical Council/Thieme
  2. United States Pharmacopeial Convention: Cranberry liquid preparation. United States Pharmacopeia (USP 36) - The National Formulary (NF 31). 2013, Rockville, MD: United States Pharmacopeial Convention, Inc
  3. Forster DA, Denning A, Wills G, Bolger M, McCarthy E: Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006, 6: 21-10.1186/1471-2393-6-21.View ArticlePubMedPubMed Central
  4. Glover DD, Amonkar M, Rybeck BF, Tracy TS: Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003, 188 (4): 1039-1045. 10.1067/mob.2003.223.View ArticlePubMed
  5. Glover DD, Rybeck BF, Tracy TS: Medication use in a rural gynecologic population: prescription, over-the-counter, and herbal medicines. Am J Obstet Gynecol. 2004, 190 (2): 351-357. 10.1016/j.ajog.2003.08.033.View ArticlePubMed
  6. Holst L, Wright D, Haavik S, Nordeng H: The use and the user of herbal remedies during pregnancy. J Altern Complement Med. 2009, 15 (7): 787-792. 10.1089/acm.2008.0467.View ArticlePubMed
  7. Nordeng H, Bayne K, Havnen GC, Paulsen BS: Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract. 2011, 17 (3): 147-151. 10.1016/j.ctcp.2010.09.002.View ArticlePubMed
  8. Schnarr J, Smaill F: Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008, 38 (SUPPL.2): 50-57.View ArticlePubMed
  9. Mittal P, Wing DA: Urinary tract infections in pregnancy. Clin Perinatol. 2005, 32 (3): 749-764. 10.1016/j.clp.2005.05.006.View ArticlePubMed
  10. MacLean AB: Urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001, 17 (4): 273-276. 10.1016/S0924-8579(00)00354-X. discussion 276-277View ArticlePubMed
  11. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M: Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 1989, 73 (4): 576-582.PubMed
  12. Schieve LA, Handler A, Hershow R, Persky V, Davis F: Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Publ Health. 1994, 84 (3): 405-410. 10.2105/AJPH.84.3.405.View Article
  13. Farkash E, Weintraub A, Sergienko R, Wiznitzer A, Zlotnik A, Sheiner E: Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012, 162 (1): 24-27. 10.1016/j.ejogrb.2012.01.024.View ArticlePubMed
  14. Mazor-Dray E, Levy A, Sheiner E: Maternal urinary tract infection: is it an independent risk factor for adverse pregnancy outcomes?. Am J Obstet Gynecol. 2008, 199 (6): S150-View Article
  15. Jolley JA, Wing DA: Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs. 2010, 70 (13): 1643-1655. 10.2165/11538050-000000000-00000.View ArticlePubMed
  16. Berard A, Santos F, Ferreira E, Perreault S: Urinary tract infections during pregnancy. Urinary tract infections. Edited by: Peter T. 2011, Rijeka: InTech
  17. Smaill F, Vazquez JC: Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2007, 2: CD000490-PubMed
  18. Nicolle L, Bradley S, Colgan R, Rice J, Schaeffer A, Hooton T: Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005, 40 (5): 643-654. 10.1086/427507.View ArticlePubMed
  19. National Collaborating Centre for Women’s and Children’s Health: Antenatal care: routine care for the healthy pregnant woman. 2008, London: RCOG Press, http://​www.​nice.​org.​uk/​nicemedia/​pdf/​CG62FullGuidelin​eCorrectedJune20​08July2009.​pdf. Accessed 06 November 2013, 2
  20. Natural medicines comprehensive database: Cranberry monograph. http://​naturaldatabase.​therapeuticresea​rch.​com/​home.​aspx?​cs=​&​s=​ND. Accessed 06 November 2013
  21. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N: Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother. 1989, 33 (1): 92-98. 10.1128/AAC.33.1.92.View ArticlePubMedPubMed Central
  22. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP: Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010, 10: 94-10.1186/1471-2334-10-94.View ArticlePubMedPubMed Central
  23. Foo LY, Lu Y, Howell AB, Vorsa N: A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod. 2000, 63 (9): 1225-1228. 10.1021/np000128u.View ArticlePubMed
  24. Lowe FC, Fagelman E: Cranberry juice and urinary tract infections: what is the evidence?. Urology. 2001, 57 (3): 407-413. 10.1016/S0090-4295(00)01100-6.View ArticlePubMed
  25. Jepson RG, Mihaljevic L, Craig J: Cranberries for treating urinary tract infections. Cochrane Database Syst Rev. 2000, 2: CD001322-PubMed
  26. Jepson RG, Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008, 1: CD001321-PubMed
  27. Jepson RG, Williams G, Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012, 10: CD001321-PubMed
  28. Wing DA, Rumney PJ, Preslicka CW, Chung JH: Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol. 2008, 180 (4): 1367-1372. 10.1016/j.juro.2008.06.016.View ArticlePubMedPubMed Central
  29. Hess HM, Miller RK: Herbs during pregnancy. Drugs During Pregnancy and Lactation. Edited by: Schaefer C, Peters P, Miller R. 2007, London: Elsevier, 485-501. 2View Article
  30. Mills E, Dugoua JJ, Perri D, Koren G: Herbal Medicines in Pregnancy and Lactation. An evidence-Based Approach. 2006, Taylor&Francis Group: London and New YorkView Article
  31. Barnes J, Anderson L, Phillipson J: Herbal Medicines. 2007, London: Pharmaceutical Press, 3
  32. Hamann G, Campbell J, George C: Warfarin-cranberry juice interaction. Ann Pharmacother. 2011, 45 (3): e17-10.1345/aph.1P451.View ArticlePubMed
  33. Abdul MIM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ: Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Brit J Pharmacol. 2008, 154 (8): 1691-1700.View Article
  34. Zikria J, Goldman R, Ansell J: Cranberry juice and warfarin: when bad publicity trumps science. Am J Med. 2010, 123 (5): 384-392. 10.1016/j.amjmed.2009.08.019.View ArticlePubMed
  35. Norwegian Institue of Public Health: What is the Norwegian Mother and Child Cohort Study?. http://​www.​fhi.​no/​artikler/​?​id=​65519. Accessed 06 November 2013
  36. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C: Cohort profile: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol. 2006, 35 (5): 1146-1150. 10.1093/ije/dyl170.View ArticlePubMed
  37. Norwegian Institue of Public Health: The Nowegian Mother and Child Cohort Study. Questionnaire 1. http://​www.​fhi.​no/​dokumenter/​1f32a49514.​pdf. Accessed 06 November 2013
  38. Norwegian Institue of Public Health: The Nowegian Mother and Child Cohort Study. Questionnaire 3. http://​www.​fhi.​no/​dokumenter/​7b6b32b0cd.​pdf. Accessed 06 November 2013
  39. Norwegian Institue of Public Health: The Nowegian Mother and Child Cohort Study. Questionnaire 4. http://​www.​fhi.​no/​dokumenter/​9ecca1c459.​pdf. Accessed 06 November 2013
  40. Irgens LM: The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000, 79 (6): 435-439. 10.1080/j.1600-0412.2000.079006435.x.View ArticlePubMed
  41. Norwegian Institue of Public Health: Medical Birth Registry of Norway. http://​www.​fhi.​no/​artikler/​?​id=​94819]. Accessed 06 November 2013
  42. World Health Organization: International statistical classification of disease and related health problems, 10th revision. http://​apps.​who.​int/​classifications/​icd10/​browse/​2010/​en. Accessed 06 November 2013
  43. Norwegian Institue of Public Health: Definisjonsrapporter for variabler i Medisinsk fødselsregister (in Norwegian). English: Definition report for variables in the Medical Birth Registry of Norway. http://​www.​fhi.​no/​dokumenter/​8105c63e8e.​pdf. Accessed 06 November 2013
  44. Aston JL, Lodolce AE, Shapiro NL: Interaction between warfarin and cranberry juice. Pharmacotherapy. 2006, 26 (9): 1314-1319. 10.1592/phco.26.9.1314.View ArticlePubMed
  45. Duthie GG, Kyle JAM, Jenkinson AM, Duthie SJ, Baxter GJ, Paterson JR: Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem. 2005, 53 (8): 2897-2900. 10.1021/jf040393b.View ArticlePubMed
  46. Rosenkranz B, Fischer C, Meese CO, Frolich JC: Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol. 1986, 21 (3): 309-317. 10.1111/j.1365-2125.1986.tb05195.x.View ArticlePubMedPubMed Central
  47. Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y: Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol. 2005, 22 (6): 321-324. 10.1055/s-2005-873235.View ArticlePubMed
  48. Facchinetti F, Pedrielli G, Benoni G, Joppi M, Verlato G, Dante G, Balduzzi S, Cuzzolin L: Herbal supplements in pregnancy: unexpected results from a multicentre study. Hum Reprod. 2012, 27 (11): 3161-3167. 10.1093/humrep/des303.View ArticlePubMed
  49. Moussally K, Oraichi D, Berard A: Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf. 2009, 18 (6): 454-461. 10.1002/pds.1731.View ArticlePubMed
  50. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998, 280 (18): 1569-1575. 10.1001/jama.280.18.1569.View ArticlePubMed
  51. Tindle HA, Davis RB, Phillips RS, Eisenberg DM: Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alternative Ther Health Med. 2005, 11 (1): 42-49.
  52. Hanssen B, Grimsgaard S, Launso L, Fonnebo V, Falkenberg T, Rasmussen NK: Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care. 2005, 23 (1): 57-62. 10.1080/02813430510018419.View ArticlePubMed
  53. Van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, De Jong-Van Den Berg LTW: Questions about drugs: How do pregnant women solve them?. Pharm World Sci. 1994, 16 (6): 254-259.PubMed
  54. Nordeng H, Ystrom E, Einarson A: Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010, 66 (2): 207-214. 10.1007/s00228-009-0744-2.View ArticlePubMed
  55. Duff P: Pyelonephritis in pregnancy. Clin Obstet Gynecol. 1984, 27 (1): 17-31. 10.1097/00003081-198403000-00006.View ArticlePubMed
  56. McCormick T, Ashe RG, Kearney PM: Urinary tract infection in pregnancy. Obstet Gynaecol. 2008, 10 (3): 156-162. 10.1576/toag.10.3.156.27418.View Article
  57. Melve KK, Lie RT, Skjaerven R, Van Der Hagen CB, Gradek GA, Jonsrud C, Braathen GJ, Irgens LM: Registration of Down syndrome in the medical birth registry of Norway: validity and time trends. Acta Obstet Gynecol Scand. 2008, 87 (8): 824-830. 10.1080/00016340802217184.View ArticlePubMed
  58. Kubon C, Sivertsen A, Vindenes HA, Abyholm F, Wilcox A, Lie RT: Completeness of registration of oral clefts in a medical birth registry: a population-based study. Acta Obstet Gynecol Scand. 2007, 86 (12): 1453-1457. 10.1080/08037050701645090.View ArticlePubMed
  59. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P: Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009, 23 (6): 597-608. 10.1111/j.1365-3016.2009.01062.x.View ArticlePubMed
    1. The pre-publication history for this paper can be accessed here:http://​www.​biomedcentral.​com/​1472-6882/​13/​345/​prepub
Metadata
Title
Pregnancy outcome after use of cranberry in pregnancy – the Norwegian mother and child cohort study
Authors
Kristine Heitmann
Hedvig Nordeng
Lone Holst
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-345

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue